Expression of vascular endothelial growth factor in tumors and plasma from dogs with primary intracranial neoplasms

American Journal of Veterinary Research

Volumn 68, Issue 11, 2007, Pages 1239-1245

  Rossmeisl Jr , John H ^a   Duncan, Robert B ^a   Huckle, William R ^a   Troy, Gregory C ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

AGE; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; BLOOD LEVEL; BLOOD SAMPLING; BRAIN SURGERY; CANCER GRADING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; INTRACRANIAL TUMOR; MEDICAL RESEARCH; MENINGIOMA; NONHUMAN; OLIGODENDROGLIOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ANIMALS; ASTROCYTOMA; BRAIN NEOPLASMS; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOCYTOCHEMISTRY; MALE; MENINGIOMA; OLIGODENDROGLIOMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; CANIS FAMILIARIS;

EID: 36448982917     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.11.1239     Document Type: Article

References (27)

1. Berkman RA, Merrill MJ, Reinhold WC, et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993;91:153-159.
2. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
3. Harrigan MR. Angiogenic factors in the central nervous system. Neurosurgery 2003;53:1362-1376.
4. Scheidegger P, Weiglhofer W, Suarez S, et al. Vascular endothelial growth factor (VEGF) and its receptor in tumor-bearing dogs. Biol Chem 1999;380:1449-1454.
5. Graham JC, Myers RK. The prognostic significance of angiogenesis in mammary tumors, J Vet Intern Med 1999;13:416-418.
6. Wergin MC, Ballmer Hofer K, Roos M, et al. Preliminary study of plasma vascular endothelial growth factor (VEGF) during low- and high-dose radiation therapy in of dogs with spontaneous tumors. Vet Radiol Ultrasound 2004;45:247-254.
7. Restucci B, Maiolino P, Paciello O, et al. Expression of vascular endothelial growth factor in canine mammary tumors. Vet Pathol 2002;39:488-493.
8. Platt SR, Scase TJ, Adams V, et al. Vascular endothelial growth factor expression in canine intracranial meningiomas and association with patient survival. J Vet Intern Med 2006;20:663-668.
9. Pistolesi S, Boldrini L, Gisfredi S, et al. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Neuropathol Appl Neurobiol 2004;30:118-125.
10. Huang H, Held-Feindt J, Buhl R, et al. Expression of VEGF and its receptors in different brain tumors. Neurol Res 2005;27:371-377.
11. Chaundry IH, O'Donovan DGO, Brenchley PEC, et al. Vascular endothelial growth factor expression correlated with tumor grade and vascularity in gliomas. Histopathology 2001;39:409-415.
12. Troy GC, Huckle WR, Rossmeisl JH, et al. Endostatin and vascular endothelial growth factor concentrations in healthy dogs, dogs with selected neoplasia, and dogs with non-neoplastic diseases. J Vet Intern Med 2006;20:144-150.
13. Clifford CA, Hughes D, Beal MW, et al. Plasma vascular endothelial growth factor concentrations in healthy dogs and dogs with hemangiosarcoma. J Vet Intern Med 2001;15:131-135.
14. Clifford CA, Hughes D, Beal MW, et al. Vascular endothelial growth factor concentrations in body cavity effusions in dogs. J Vet Intern Med 2002;16:164-168.
15. Dickinson PJ, Roberts BN, Higgins RJ, et al. Expression of receptor tyrosine kinases VEGFR-1 (FLT-1), VEGFR-2 (KDR), EGFR-1, PDGFRα, and c-Met in canine primary brain tumors. Vet Comp Oncol 2006;4:132-140.
16. Kleinheus P, Cavenee WK. WHO classification of tumors. Pathology and genetics - tumors of the nervous system. Lyon, France: IARC Press, 2000;176-184.
17. Koestner A, Bilzer T, Schulman FY, et al. Histological classification of tumors of the nervous system of domestic animals. 2nd series, Vol 5. Washington, DC: Armed Forces Institute of Pathology; 1999.
18. Morokoff AP, Novak U. Targeted therapy for malignant gliomas. J Clin Neurosci 2004;11:807-818.
19. Lamszus K, Ulbricht U, Matschke J, et al. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A. Clin Cancer Res 2003;9:1399-1405.
20. Pietsch T, Vaher MM, Wolf H, et al. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 1997;93:109-117.
21. Oehring RD, Miletic M, Valter MM, et al. Vascular endothelial growth factor in astroeytic gliomas - a prognostic factor? J Neurooncol 1999;45:117-125.
22. Korshunov A, Golanov A, Sycheva R. Immunohistochemical markers for prognosis of oligodendroglial neoplasms. J Neurooncol 2002;58:237-253.
23. Korshunov A, Golanov A. The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendrogliomas. An analysis of 91 cases. J Neurooncol 2000;48:13-19.
24. Snyder JM, Shofer FS, Van Winkle TJ, et al. Canine intracranial primary neoplasia: 173 cases (1986-2003). J Vet Intern Med 2006; 20:669-075.
25. Takano S, Yoshii Y, Kondo S, et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 1996;56:2185-2190.
26. Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and non-malignant disease. Cancer 1999;85:178-187.
27. Salven P, Orpana A, Joensuu H. Leukocytes and platelets with cancer contain high levels of vascular endothehal growth factor. Clin Cancer Res 1999;5:487-491.